Form 4: Agilent Technologies VP Acquires Over 9,000 Shares Through RSU Grant

Agilent Technologies' Corporate Controller, Rodney Gonsalves, has acquired 9,031 shares of common stock through a restricted stock unit grant, increasing his direct beneficial ownership.

Summary

• Rodney Gonsalves, the V.P., Corporate Controller of Agilent Technologies, Inc. (A), acquired 9,031 shares of common stock.
• The transaction date for this acquisition was July 16, 2025, with the shares valued at $113.43 per share.
• These shares were granted as Restricted Stock Units (RSUs) under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3.
• The RSUs are scheduled to vest 100% on July 16, 2026, which marks the 1-year anniversary of the grant date, and are subject to an additional 1-year post-vest holding period.
• Following this reported transaction, Rodney Gonsalves directly beneficially owns 30,971.6912 shares.
• His total beneficial ownership also includes 40.192 shares held indirectly through the Gonsalves Trust.
• The reported beneficial ownership also incorporates 123.2675 shares acquired via an Employee Stock Purchase Plan and 31.532 shares acquired through the company's dividend reinvestment plan, which have been deferred.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive, even if through an RSU grant, generally signals confidence in the company's future. It aligns management's interests with shareholders and is a positive, though routine, event.

Positives

• A senior executive, the V.P., Corporate Controller, is increasing their equity stake in the company, which can signal confidence in future performance and aligns management's interests with shareholders.
• The acquisition is through a restricted stock unit grant, a common form of equity compensation that incentivizes long-term commitment and performance.

Future Outlook

The restricted stock units granted are scheduled to vest on July 16, 2026, indicating a future milestone for the executive's equity compensation and continued alignment with company performance.

Industry Context

This transaction represents a routine equity compensation grant to a senior executive, a common practice across various industries, including technology and life sciences, aimed at aligning management incentives with long-term shareholder value. It does not provide specific insights into broader industry trends for Agilent Technologies.

Comparison to Industry Standards

• The grant of restricted stock units to a corporate officer is a standard practice in publicly traded companies across diverse sectors, including technology and life sciences, to incentivize long-term performance and executive retention.
• Companies such as Thermo Fisher Scientific, Danaher Corporation, and PerkinElmer, which operate in similar or related life sciences and diagnostics fields, commonly utilize comparable equity compensation plans for their executives.
• The specified vesting schedule (100% at 1-year anniversary) and the 1-year post-vest holding period are typical structures for such equity grants, reflecting industry norms for executive incentive programs.

Corporate Governance

Related Party Transactions

• Shares are indirectly held by the Gonsalves Trust, for which Rodney and Rochelle Gonsalves serve as trustees, constituting a disclosed related party holding.

Stakeholder Impact

• Shareholders: The acquisition of shares by a key executive may be viewed positively, signaling management's belief in the company's value and potentially boosting investor confidence.
• Employees: The grant of RSUs is part of the company's compensation strategy, which can be a positive for employee retention and motivation, particularly for senior leadership.

Next Steps

• The 9,031 restricted stock units are scheduled to vest on July 16, 2026.
• The shares acquired through the dividend reinvestment plan have been deferred.

Key Dates

Recommendation

Keywords

Agilent Technologies, A, Rodney Gonsalves, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Equity Compensation, Beneficial Ownership, Corporate Controller, Stock Plan